FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Methocarbamol Tablets
Status: Currently in Shortage
»Date first posted: 08/17/2018
»Therapeutic Categories: Analgesia/Addiction

Expand all

AustarPharma, LLC (Reverified 11/21/2018)

Company Contact Information:
805-447-9866 ext. 259

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Distributed by Golden State Medical Supply, Inc.: 500 mg, 100 ct (NDC 60429-118-01); 500 ct (NDC 60429-118-05) Distributed by Virus Pharmaceuticals: 500 mg, 100 ct (NDC 69543-134-10); 500 ct (NDC 69543-134-50) Currently available Shortage of active ingredient
Distributed by Golden State Medical Supply, Inc.: 750 mg, 100 ct (NDC 60429-119-01); 500 ct (NDC 60429-119-05) Distributed by Virtus Pharmaceuticals: 750 mg, 100 ct (NDC 69543-135-10); 500 ct (NDC 69543-135-50) Currently available Shortage of active ingredient

Bayshore Pharmaceuticals (Revised 11/21/2018)

Company Contact Information:
973-315-1819

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg, 100 ct (NDC 76385-123-01); 500 ct (NDC 76385-123-50) Limited supply, on allocation Increased production on-going Increase in demand
750 mg, 100 ct (NDC 76385-124-01); 500 ct (NDC 76385-124-50) Limited supply, on allocation Increased production on-going Increase in demand

Camber Pharmaceuticals Inc. (New 08/17/2018)

Company Contact Information:
866-827-3647

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg, 100 ct (NDC 31722-533-01); 500 ct (NDC 31722-533-05) Estimated release Nov 2018 API shortage Shortage of active ingredient
750 mg, 100 ct (NDC 31722-534-01); 500 ct (NDC 31722-534-05) Estimated release Nov 2018 API shortage Shortage of active ingredient

Granules Pharmaceuticals Inc. (New 08/17/2018)

Company Contact Information:
877-770-3183

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg, 100 ct (NDC 70010-754-01); 500 ct (NDC 70010-754-05) Available Available Other
750 mg, 100 ct (NDC 70010-770-01); 500 ct (NDC 70010-770-05) Available Available Other

Oxford Pharmaceuticals, LLC (New 08/17/2018)

Company Contact Information:
256-759-6905

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg, 100 ct (NDC 69584-611-10); 500 ct (NDC 69584-611-50); 1000 ct (NDC 69584-611-90) Currently not available. Estimated release Jan 2019 Newly acquired product. Other
750 mg, 100 ct (NDC 69584-612-10); 500 ct (NDC 69584-612-50); 1000 ct (NDC 69584-612-90) Currently not available. Estimated release Jan 2019 Newly acquired product Other

Solco Healthcare US, LLC (New 08/17/2018)

Company Contact Information:
866-931-9829

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg, 100 ct (NDC 43547-0405-10); 500 ct (NDC 43547-0405-50) On allocation to contract customers only due to increase in product demand. No interruption in supply. Increased customer demand for the product Shortage of active ingredient
750 mg, 100 ct (NDC 43547-0226-10); 500 ct (NDC 43547-0226-50) On allocation to contract customers only due to increase in product demand. No interruption in supply. Increased customer demand for the product Shortage of active ingredient

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English